Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 5, keine Gesamtzahl für „pharmacokinetics“
Suchtreffer
Begriffe & Kennungen
Champix · 4.5 · Varenicline did not alter the pharmacokinetics of warfarin. Prothrombin time (INR) was not affected by varenic
Eintrag öffnenChampix · 4.5 · Varenicline did not alter the steady-state pharmacokinetics of digoxin.
Eintrag öffnenChampix · 4.5 · Varenicline did not alter the steady-state pharmacokinetics of digoxin.
Eintrag öffnenChampix · 4.5 · Varenicline did not alter the steady-state pharmacokinetics of digoxin.
Eintrag öffnenCholib · 4.5 · Effects on the pharmacokinetics of other medicinal products Fenofibrate and simvastatin are not CYP 3A4 inhibi
Eintrag öffnenCholib · 4.5 · Effects on the pharmacokinetics of other medicinal products Fenofibrate and simvastatin are not CYP 3A4 inhibi
Eintrag öffnenChronopharmakokinetik
Eintrag öffnenCibinqo · 4.5 · Potential for abrocitinib to affect pharmacokinetics of other medicinal products
Eintrag öffnenCibinqo · 4.5 · Potential for other medicines to affect pharmacokinetics of abrocitinib
Eintrag öffnenCinacalcet Accordpharma · 4.5 · Pantoprazole: Co-administration of pantoprazole (80 mg od) did not alter the pharmacokinetics of cinacalcet.
Eintrag öffnenCinacalcet Accordpharma · 4.5 · Sevelamer: Co-administration of sevelamer (2,400 mg tid) did not affect the pharmacokinetics of cinacalcet.
Eintrag öffnenCinacalcet Accordpharma · 4.5 · The lack of effect of cinacalcet on the pharmacokinetics of R- and S-warfarin and the absence of auto- inducti
Eintrag öffnenCinacalcet Accordpharma · 4.5 · Warfarin: Multiple oral doses of cinacalcet did not affect the pharmacokinetics or pharmacodynamics (as measur
Eintrag öffnenCinacalcet Viatris (previously Cinacalcet Mylan) · 4.5 · Co-administration of calcium carbonate (single 1,500 mg dose) did not alter the pharmacokinetics of cinacalcet
Eintrag öffnenCinacalcet Viatris (previously Cinacalcet Mylan) · 4.5 · Co-administration of pantoprazole (80 mg, once daily) did not alter the pharmacokinetics of cinacalcet.
Eintrag öffnenCinacalcet Viatris (previously Cinacalcet Mylan) · 4.5 · Co-administration of sevelamer (2,400 mg, three times a day) did not affect the pharmacokinetics of cinacalcet
Eintrag öffnenCinacalcet Viatris (previously Cinacalcet Mylan) · 4.5 · Multiple oral doses of cinacalcet did not affect the pharmacokinetics or pharmacodynamics (as measured by prot
Eintrag öffnenCinacalcet Viatris (previously Cinacalcet Mylan) · 4.5 · The lack of effect of cinacalcet on the pharmacokinetics of R-and S-warfarin and the absence of auto- inductio
Eintrag öffnenClopidogrel / Acetylsalicylic acid Viatris (previously Clopidogrel / Acetylsalicylic acid Mylan) · 4.5 · The pharmacokinetics of digoxin or theophylline were not modified by the co-administration of clopidogrel. Ant
Eintrag öffnenClopidogrel BGR (previously Zylagren) · 4.5 · The pharmacokinetics of digoxin or theophylline were not modified by the co-administration of clopidogrel. Ant
Eintrag öffnen